Impairment of Insulin Signalling Pathway: AMPKα/SIRT1 and Pathophysiological Involvement of Gut Microbiota in Monosodium Glutamate Induced Polycystic Ovary Syndrome with Palliati - Egyptian Knowledge Bank

317347

Impairment of Insulin Signalling Pathway: AMPKα/SIRT1 and Pathophysiological Involvement of Gut Microbiota in Monosodium Glutamate Induced Polycystic Ovary Syndrome with Palliati

Article

Last updated: 03 Jan 2025

Overview Similar Items

Article

The Role of AMP-activated Protein Kinase (AMPK) in Pathogenesis of Polycystic Ovary Syndrome

Article

Cross-Talk between Apelin, Insulin Resistance, Thyroid Hormones, and Cardio-metabolic Risk Factors in Polycystic Ovary Syndrome

Article

Metabolic syndrome: A Review Involving the Hedgehog Pathway, PGC-1α , and GLP Roles

Article

Ameliorative Impact of High Inositol Diet on the Insulin Resistance and Metabolite Hormones among Women with Polycystic Ovary Syndrome

Article

GHRELIN IN POLYCYSTIC OVARIAN SYNDROME WITH AND WITHOUT DIABETES MELLITUS IN EGYPTIAN POPULATION

Article

Role Of Insulin Like Growth Factor in Polycystic Ovary Syndrome

Article

Monosodium Glutamate Induced Hepatotoxicity and Oxidative Stress: Pathophysiological, Biochemical and Electron Microscopic Study

Article

An AMPK activator, Metformin, ameliorates aging-related oxidative hepatic injury induced by D-galactose via Irisin/ SIRT1 pathway, a possible role of PPAR-γ besides its antioxida

Article

Hyperglycemia and hyperinsulinemia induced hepatocellular autophagy in male mice

Article

Metabolic Syndrome: Pathophysiology and Treatment